MorphoSys AG

NASDAQ: MOR · Real-Time Price · USD
18.96
0.45 (2.43%)
At close: Aug 02, 2024, 10:00 PM

MorphoSys Cash Flow Statement

Financials in EUR. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-189.73M -151.06M -514.46M
Depreciation & Amortization
10.54M 10.54M 10.09M
Stock-Based Compensation
27.37M 3.64M 2.59M
Other Working Capital
-49.66M -12.18M -2.36M
Other Non-Cash Items
-150.03M -346.96M 209.92M
Deferred Income Tax
-1.19M 168.58M -76.59M
Change in Working Capital
7.21M -51.44M -112.99M
Operating Cash Flow
-295.84M -366.71M -481.45M
Capital Expenditures
-2.87M -15.23M -26.16M
Cash Acquisitions
4.58M n/a -1.21B
Purchase of Investments
-3.15B -1.88B -2.19B
Sales Maturities Of Investments
3.15B 2.24B 2.59B
Other Investing Acitivies
18.22M 4.23M 1.62M
Investing Cash Flow
15.37M 345M -831.01M
Debt Repayment
n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a
Dividend Paid
n/a n/a n/a
Other Financial Acitivies
43M 311.42M 1.32B
Financial Cash Flow
43M 311.42M 1.32B
Net Cash Flow
-243.85M 279.1M 13.45M
Free Cash Flow
-298.71M -381.93M -507.6M